ITRUST MEDTECH INC.
Company Profile
iTRUST MedTech – Company Profile
1. Company History
Technological Origins (2019): Originated from a cross-disciplinary collaboration between Radiation Technology Co., LTD (a major semiconductor optics supplier) and Point Robotics MedTech Inc. This partnership successfully integrated semiconductor-grade high-precision optical technology into clinical microbial identification.
Official Spin-off (2024): Following technological maturity and commercial readiness, the company officially spun off from Point MedTech in July 2024 to establish iTRUST MedTech Co., Ltd., focusing exclusively on the R&D of AI optical medical diagnostic products.
2. Company Philosophy
Driven by the mission to elevate human health through technology, iTRUST MedTech holds "mitigating the threats of pathogenic bacteria and antimicrobial resistance (AMR) to humanity" as its core value. We firmly believe that no one should face life-threatening risks due to antibiotic abuse or drug resistance, and that everyone deserves access to affordable, highly efficient, and comprehensive healthcare.
3. Value Proposition
As a global pioneer deeply integrating optical technology with AI big data analytics, iTRUST MedTech is charting a brand-new path in microbial diagnostic instruments.
Dual-in-One Verification: Simultaneously satisfies both "microbial identification" and "antimicrobial resistance (AMR) prediction."
Four Core Advantages: Rapid turnaround time (drastically shortening clinical wait times), intuitive operation (one-click detection with a smart UI), non-toxic/safe reagents, and affordability (significantly easing the financial burden on healthcare institutions).
4. Future Outlook
Advancing International Certifications: The company is actively preparing regulatory submissions for the US FDA (via the De-Novo pathway for innovative medical devices) and Taiwan TFDA, accelerating full-scale product commercialization and global market expansion.
Expanding Application Tracks: Beyond the clinical human medicine market (anchored by the flagship AIRDIS System), the company is extending its reach with the AIRMAB System—tailored for non-clinical applications (such as companion/livestock animals, food safety, and environmental monitoring)—to create a cross-domain, intelligent microbial monitoring ecosystem.
5. Market Achievements & Reputation
Clinical Validation by Top-tier Medical Institutions: iTRUST MedTech has partnered with leading medical centers and laboratory experts—including National Taiwan University Hospital (NTUH) Main Campus (led by Prof. Hao-Chieh Chiu's team), NTUH Hsinchu Branch (Department of Laboratory Medicine), and China Medical University Hospital (Central Laboratory)—to conduct large-scale clinical feasibility trials and data collection, covering over 90% of common bacteria and fungi in Taiwan.
National Recognition and Awards:
Honored with the Innoaward National Innovation Award (Clinical Innovation Award & Innovation Renewal Award).
Awarded the Bronze Medal in the Smart Healthcare Category at the NHQA (National Healthcare Quality Award) and certified with the SNQ (Symbol of National Quality).
1. Company History
Technological Origins (2019): Originated from a cross-disciplinary collaboration between Radiation Technology Co., LTD (a major semiconductor optics supplier) and Point Robotics MedTech Inc. This partnership successfully integrated semiconductor-grade high-precision optical technology into clinical microbial identification.
Official Spin-off (2024): Following technological maturity and commercial readiness, the company officially spun off from Point MedTech in July 2024 to establish iTRUST MedTech Co., Ltd., focusing exclusively on the R&D of AI optical medical diagnostic products.
2. Company Philosophy
Driven by the mission to elevate human health through technology, iTRUST MedTech holds "mitigating the threats of pathogenic bacteria and antimicrobial resistance (AMR) to humanity" as its core value. We firmly believe that no one should face life-threatening risks due to antibiotic abuse or drug resistance, and that everyone deserves access to affordable, highly efficient, and comprehensive healthcare.
3. Value Proposition
As a global pioneer deeply integrating optical technology with AI big data analytics, iTRUST MedTech is charting a brand-new path in microbial diagnostic instruments.
Dual-in-One Verification: Simultaneously satisfies both "microbial identification" and "antimicrobial resistance (AMR) prediction."
Four Core Advantages: Rapid turnaround time (drastically shortening clinical wait times), intuitive operation (one-click detection with a smart UI), non-toxic/safe reagents, and affordability (significantly easing the financial burden on healthcare institutions).
4. Future Outlook
Advancing International Certifications: The company is actively preparing regulatory submissions for the US FDA (via the De-Novo pathway for innovative medical devices) and Taiwan TFDA, accelerating full-scale product commercialization and global market expansion.
Expanding Application Tracks: Beyond the clinical human medicine market (anchored by the flagship AIRDIS System), the company is extending its reach with the AIRMAB System—tailored for non-clinical applications (such as companion/livestock animals, food safety, and environmental monitoring)—to create a cross-domain, intelligent microbial monitoring ecosystem.
5. Market Achievements & Reputation
Clinical Validation by Top-tier Medical Institutions: iTRUST MedTech has partnered with leading medical centers and laboratory experts—including National Taiwan University Hospital (NTUH) Main Campus (led by Prof. Hao-Chieh Chiu's team), NTUH Hsinchu Branch (Department of Laboratory Medicine), and China Medical University Hospital (Central Laboratory)—to conduct large-scale clinical feasibility trials and data collection, covering over 90% of common bacteria and fungi in Taiwan.
National Recognition and Awards:
Honored with the Innoaward National Innovation Award (Clinical Innovation Award & Innovation Renewal Award).
Awarded the Bronze Medal in the Smart Healthcare Category at the NHQA (National Healthcare Quality Award) and certified with the SNQ (Symbol of National Quality).
